Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 597

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 597
---
.The Group’s business, reorganization and general information OmnigenicsAI Corp (“Omnigenics” or the “Company”) is a company with limited liability, organized under the laws of the Cayman Islands on January 9, 2024, originally under the name Heritas Cayco. The Company was incorporated for the purpose of making acquisitions and investments, with the objective of acting as the publicly traded holding company for its subsidiary. On March 18, 2024, Heritas Cayco formally changed its name to OmnigenicsAI Corp. On February 26, 2024, the Company underwent a reorganization pursuant to which Heritas Ltd., an exempted company organized under the laws of the Cayman Islands, contributed to OmnigenicsAI a wholly owned subsidiary of Heritas Ltd., all the issued and outstanding shares in its subsidiary, Heritas SAU (“Heritas Argentina”). Heritas SAU, officially formed on July 10, 2015, is a company incorporated and domiciled in Argentina. Together, OmnigenicsAI and its subsidiary, Heritas SAU, are referred to as the “Group.” As a result of this contribution, Heritas Argentina became a wholly owned subsidiary of OmnigenicsAI. In exchange for this contribution, OmnigenicsAI issued 30,000,000shares with a par value of US$0.0001 per share to Heritas Ltd., thereby completing the reorganization. This entailed, in the year ended June 30, 2024, a reduction of the share capital from US$13,059 to US$3,000. The effect of the reduction in share capital by US$10,059 and the related inflation adjustment on share capital of US$39,826 was impacted by an offsetting in share premium in accordance with the movement identified as “Reorganization effects” in the Combined Statement of Changes in Shareholders’ Deficit. On March 25, 2024, the Company entered into a Business Combination Agreement (“BCA”) with APx Acquisition Corp. I (“SPAC”), Heritas Merger Sub Limited and MultiplAI Health Ltd., a private limited company formed under the laws of England and Wales, to effectuate a business combination. The transaction, designed to transition OmnigenicsAI into a publicly traded entity, involves the merger of Heritas Merger Sub Limited, a wholly -ownedsubsidiary of OmnigenicsAI incorporated in the Cayman Islands, with and into SPAC, a company also incorporated